Tonawanda, NY – May 14, 2024 – Pine Pharmaceuticals is pleased to announce the return of edetate disodium 1.5%, further expanding its product portfolio and reinforcing its commitment to providing high-quality solutions for healthcare providers.
Packaged in a 1 mL single-use vial, edetate disodium 1.5% offers the convenience of room-temperature storage, providing a ready-to-use ophthalmic solution for health systems nationwide. Additionally, its extended dating helps optimize inventory management, ultimately saving time and reducing costs.
“At Pine Pharmaceuticals, we are committed to supporting our partners with high-quality, reliable products,” said Alfonse J. Muto, Pharm.D. “We are pleased to offer edetate disodium once again, ensuring that practices have access to this essential product.”
Our dedicated team is available to assist with ordering, making the procurement process seamless and efficient. For more information or to place an order, please contact our team.
About Pine Pharmaceuticals LLC
Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in the preparation of high-quality, ready-to-administer compounds and repackaged products. As a best-in-class partner, Pine Pharmaceuticals is committed to meeting the FDA’s stringent cGMP requirements while supporting hospitals, surgery centers, and practices nationwide. For more information, please visit www.pinepharmaceuticals.com or call 844-218-4138 to learn more about our products and services.
©2025 Pine Pharmaceuticals. All rights reserved.